SCHEMBL6795181

SCHEMBL6795181

NC(=O)c1ccc(-c2cccc3c2C(CCCCN2CCN(c4ccc(-c5ccccc5)cc4)CC2)(C(=O)O)c2ccccc2-3)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 9/20 0.46
FAAH O00519 7/20 0.46
HTR7 P34969 2/20 0.43
DRD2 P14416 7/20 0.41
DRD4 P21917 4/20 0.41
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR1A P08908 2/20 0.39
HTR2A P28223 1/20 0.39
TNKS O95271 1/20 0.39
PARP1 P09874 1/20 0.39
PARP14 Q460N5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6791990 0.90 DRD3 (0.46) DRD3FAAHHTR7DRD2DRD4
SCHEMBL6789354 0.85 HTR1A (0.47) DRD3FAAHHTR7DRD2DRD4
SCHEMBL6792849 0.81 DRD3 (0.41) DRD3FAAHHTR7DRD2HTR1A
SCHEMBL6790993 0.80 DRD3 (0.40) DRD3FAAHHTR7DRD2DRD4
SCHEMBL6795176 0.77 PKM (0.52) DRD3HTR7DRD2DRD4HTR1A
SCHEMBL6790535 0.76 HTR1A (0.50) DRD3HTR7DRD2HTR1AHTR2A
SCHEMBL6770311 0.75 HTR1A (0.49) DRD3HTR7DRD2HTR1A
SCHEMBL7049218 0.75 NOS3 (0.42) DRD3SLC6A2
SCHEMBL6793118 0.75 HTR7 (0.46) DRD3HTR7DRD2HTR1AHTR2A
SCHEMBL6792470 0.74 HTR7 (0.45) DRD3HTR7DRD2DRD4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818644-B1 FLUORENE-9-CARBOXYLIC AMIDES; INHIBITORS OF MICROSOMAL TRIGLYSERIDE-TRANSFER PROTEIN (MTP); ANTILIPEMIC AGENTS; ATHEROSCLEROSIS, DIABETES, EATING DISORDERS, AND PANCREATITIS BOEHRINGER INGELHEIM PHARM GMBH & CO, KG (DE) 2004-11-16 US disclosed